alpha-Lipoic acid prevents cisplatin-induced acute kidney injury in rats

Nephrol Dial Transplant. 2009 Sep;24(9):2692-700. doi: 10.1093/ndt/gfp176. Epub 2009 Apr 17.

Abstract

Background: Cisplatin-induced nephropathy has been related to increased lipid peroxide formation and decreased activity of antioxidant enzymes in the kidney. The present study aimed to examine whether treatment with alpha-lipoic acid (alpha-LA) prevents the cisplatin-induced nephrotoxicity.

Methods: Two groups of rats were treated with cisplatin, one of which being cotreated with alpha-LA. The control group was treated with vehicle only. Four days later, the expression of aquaporins and sodium transporters was determined in the kidney by immunoblotting and immunohistochemistry. The arginine vasopressin-stimulated generation of cAMP was measured by radioimmunoassay. The expression of nitric oxide synthases (NOS) was determined by immunoblotting. The mRNA expression of endothelin-1 (ET-1) and tumour necrosis factor (TNF)-alpha was measured by real-time PCR. Apoptosis was examined by TUNEL staining.

Results: Following the treatment with cisplatin, urinary volume and fractional excretion of sodium increased. Accordingly, the expression of aquaporins 1-3, Na,K-ATPase, NHE3 and NKCC2 was decreased. The expression of adenylyl cyclase VI and vasopressin-stimulated cAMP generation was decreased. The expression of inducible NOS was increased, while that of endothelial NOS decreased. The ET-1 expression was increased. TUNEL-positive cells were increased, in association with an increased expression of TNF-alpha. alpha-LA treatment prevented dysregulation of these parameters and resumed the renal function.

Conclusion: alpha-LA may prevent the cisplatin-induced nephrotoxicity, possibly through preserving the activities of NO and ET systems and inhibiting the development of apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclases / metabolism
  • Animals
  • Antineoplastic Agents / antagonists & inhibitors*
  • Antineoplastic Agents / toxicity*
  • Antioxidants / pharmacology*
  • Apoptosis / drug effects
  • Aquaporins / metabolism
  • Cisplatin / antagonists & inhibitors*
  • Cisplatin / toxicity*
  • Endothelins / genetics
  • Gene Expression / drug effects
  • Kidney / drug effects*
  • Kidney / injuries*
  • Kidney / pathology
  • Kidney / physiopathology
  • Lipid Peroxidation / drug effects
  • Male
  • Nitric Oxide Synthase / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Thioctic Acid / pharmacology*

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Aquaporins
  • Endothelins
  • RNA, Messenger
  • Thioctic Acid
  • Nitric Oxide Synthase
  • Adenylyl Cyclases
  • adenylyl cyclase 6
  • Sodium-Potassium-Exchanging ATPase
  • Cisplatin